Case Overview

When Finland-based wearable health technology pioneer Oura Health Oy filed suit against French smart ring startup Circular SAS in May 2022, the case spotlighted one of the most competitive emerging segments in consumer health technology. Filed in the Western District of Texas before Chief Judge Alan D. Albright, the dispute centered on two granted U.S. patents covering smart ring biometric monitoring technology — and the accused products were Circular’s own smart ring and companion app. After nearly two years of litigation spanning 713 days, the district court did not reach a verdict on the merits. Instead, Judge Albright granted a joint motion to stay the case pending the final determination of International Trade Commission (ITC) Investigation No. 337-TA-1398 — effectively placing the patent infringement action on hold while a parallel federal trade proceeding runs its course.

The Parties

Patents at Issue

This case involved two U.S. patents covering smart ring biometric monitoring technology that formed the foundation of Oura’s infringement claims.

• • U.S. Patent No. 10,893,833 B2 — directed to wearable ring-form biometric monitoring technology
• • U.S. Patent No. 10,842,429 B2 — covering related physiological measurement and sensing systems in ring-form wearables

The Accused Products

Circular’s **Circular Ring** hardware device and the companion **Circular App** were the accused infringing products. These products constitute Circular SAS’s entire market offering, meaning a successful infringement finding could have threatened the company’s continued U.S. market operation.

Legal Representation

Plaintiff (Oura Health): ArentFox Schiff, Patterson & Sheridan LLP, and Potter Minton PC — a formidable multi-firm alliance with attorneys including Abelino Reyna, Barden Todd Patterson, Michael E. Jones, and Jasjit Vidwan, among others.

Defendant (Circular SAS): Ice Miller LLP, Cadwell Clonts Reeder & Thomas LLP, Davis & Santos PC, and SoCal IP Law Group LLP — represented by Kevin E. Cadwell, Jonathan P. Pearce, T. Earl LeVere, Tom Rammer, and Caroline N. Small.

The Verdict & Legal Analysis

Outcome

Case No. 6:22-cv-00478 was stayed and administratively closed by Judge Alan D. Albright pursuant to the parties’ Joint Motion to Stay Action Pending ITC Determination. The court ordered the case held in abeyance until ITC Investigation No. 337-TA-1398 reaches a final determination — including the exhaustion of any appeals and judicial review. No damages were awarded, no injunction issued, and no merits determination was rendered at the district court level. The case remains legally alive, contingent on ITC outcome.

Verdict Cause Analysis: The ITC-District Court Parallel Strategy

This case exemplifies the dual-track litigation strategy increasingly employed by patent holders in product-based infringement disputes. Filing simultaneously at the ITC under Section 337 and in district court allows plaintiffs to pursue both exclusion orders (ITC’s primary remedy) and monetary damages (district court’s domain).

The ITC’s 337-TA-1398 investigation directly implicated the same patents and products at issue in the district court. Once that investigation was underway, the logical — and judicially efficient — outcome was a stay. District courts routinely stay parallel patent actions pending ITC determinations because ITC findings on validity and infringement carry significant persuasive weight in subsequent district court proceedings, staying avoids inconsistent rulings on overlapping claim construction issues, and both parties conserve resources pending a potentially dispositive federal agency determination.

The joint nature of the stay motion is legally significant. It signals that Circular SAS, rather than resisting the stay, agreed it was preferable — possibly indicating confidence in ITC defenses, resource constraints, or a strategic preference for the ITC forum’s procedural timeline.

Legal Significance

This case reinforces several important procedural principles for wearable technology patent litigation:

• ITC proceedings as leverage: The threat or pendency of a Section 337 investigation can reshape district court litigation strategy entirely, including influencing willingness to jointly seek stays.
• Administrative closure vs. dismissal: The case was administratively closed — not dismissed — preserving Oura’s ability to reopen proceedings once ITC finality is achieved.
• Judge Albright’s court: The Western District of Texas remains a significant venue for patent cases, though post-*In re: Apple* transfer jurisprudence has reshaped filing patterns in this district.

Industry & Competitive Implications

The smart ring wearable market is rapidly expanding, with biometric health monitoring becoming a mainstream consumer category. Oura Health’s aggressive IP enforcement signals that foundational wearable ring patents will be vigorously defended against market entrants.

For the broader wearable health technology sector, this case highlights:

• Patent portfolio depth matters: Oura’s ability to assert multiple patents across both hardware sensing and application-layer claims creates layered enforcement options.
• International dimensions: Circular SAS’s French origins and the ITC’s jurisdiction over imported goods illustrates how domestic patent enforcement intersects with global supply chains.
• Startup vulnerability: Hardware startups entering patent-dense categories face asymmetric litigation risk; even a stayed case consumes substantial legal resources.

Licensing discussions or settlement remain possible once ITC proceedings conclude — a common resolution pathway when both parties have invested heavily in parallel proceedings. Industry observers should monitor the 337-TA-1398 determination closely, as its outcome will directly govern whether district court litigation resumes.